GSK4528287 clinical trials

A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants

This study is testing a new medicine, GSK4528287, for bowel conditions like ulcerative colitis for the very first time in people. We want to see if it's safe, how the body handles it, and if it works as expected. We'll start with small doses in healthy volunteers.